德国海因斯贝格2020年4月至2022年11月跨多个变异株波与疫苗接种活动的SARS-CoV-2血清转化、再感染和中和作用纵向研究
该研究在德国海因斯贝格对1446名年龄2至103岁(平均50岁)的暴发队列进行31个月纵向血清流行病学监测,在2020年10月至2022年11月的五次随访中分析急性感染、血清转化和病毒中和作用。结果显示S特异性IgA在感染后短期下降而IgG稳定,接种疫苗后两者均显著上升;感染后S IgG预测半衰期为18个月;所有组对Omicron BQ.1.18和XBB.1.5的交叉中和作用均很低。结论为感染和/或疫苗接种未使人群获得针对Omicron变异株的交叉保护。
要点
- S特异性IgA感染后短期下降,IgG稳定,接种疫苗后两者均显著上升。
- 感染后S IgG预测半衰期为18个月。
- 所有组对Omicron BQ.1.18和XBB.1.5交叉中和作用均很低。
核心结论
- 感染和/或疫苗接种未使人群获得针对Omicron变异株的交叉保护。
研究设计与样本
- 31个月纵向血清流行病学研究中纳入1446名参与者,平均年龄50岁,年龄范围2至103岁,起始于2020年2月海因斯贝格首次SARS-CoV-2超级传播事件。
- 在2020年10月至2022年11月的五次随访中分析急性感染、血清转化和病毒中和作用,并检查针对SARS-CoV-2 Omicron变异株的细胞免疫和交叉保护性免疫。
主要发现
- SARS-CoV-2刺突(S)特异性IgA在感染后不久下降,而IgG保持稳定,两者在接种疫苗后均显著上升。
- 预测感染后S IgG半衰期为18个月。
- 核衣壳(N)特异性反应在感染后12个月内下降,但在Omicron期间上升(p < 0.0001)。
- SARS-CoV-2特异性TNF-alpha+/IFN-gamma+ CD4+ T细胞频率在感染后12个月内下降(p < 0.01)。
- SARS-CoV-2 S抗体和中和滴度在2021年4月至2022年11月间感染的三剂疫苗接种者中最高,高于2020年4月至2021年1月间感染者;所有组对Omicron BQ.1.18和XBB.1.5的交叉中和作用均很低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundSince its emergence in December 2019, over 700 million people worldwide have been infected with SARS-CoV-2 up to May 2024. While early rollout of mRNA vaccines against COVID-19 has saved many lives, there was increasing immune escape of new virus variants. Longitudinal monitoring of population-wide SARS-CoV-2 antibody responses from regular sample collection irrespective of symptoms provides representative data on infection and seroconversion/seroreversion rates.AimTo examine adaptive and cellular immune responses of a German SARS-CoV-2 outbreak cohort through several waves of infection with different virus variants.MethodsUtilising a 31-month longitudinal seroepidemiological study (n = 1,446; mean age: 50 years, range: 2-103) initiated during the first SARS-CoV-2 superspreading event (February 2020) in Heinsberg, Germany, we analysed acute infection, seroconversion and virus neutralisation at five follow-up visits between October 2020 and November 2022; cellular and cross-protective immunity against SARS-CoV-2 Omicron variants were also examined.ResultsSARS-CoV-2 spike (S)-specific IgAs decreased shortly after infection, while IgGs remained stable. Both increased significantly after vaccination. We predict an 18-month half-life of S IgGs upon infection. Nucleocapsid (N)-specific responses declined over 12 months post-infection but increased (p < 0.0001) during Omicron. Frequencies of SARS-CoV-2-specific TNF-alpha+/IFN-gamma+ CD4+ T-cells declined over 12 months after infection (p < 0.01). SARS-CoV-2 S antibodies and neutralisation titres were highest in triple-vaccinated participants infected between April 2021 and November 2022 compared with infections between April 2020 and January 2021. Cross neutralisation against Omicron BQ.1.18 and XBB.1.5 was very low in all groups.ConclusionInfection and/or vaccination did not provide the population with cross-protection against Omicron variants.
引用
- Schulte B, Richter E, Büning A, et al. A longitudinal study on SARS-CoV-2 seroconversion, reinfection and neutralisation spanning several variant waves and vaccination campaigns, Heinsberg, Germany, April 2020 to November 2022. Euro Surveill. 2024. PMID: 38940003. doi:10.2807/1560-7917.ES.2024.29.26.2300659
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。